Try our Advanced Search for more refined results
Public Policy - September, 2004
30 articles
- WIPO Mulls Proposal To Relax IP Protection In Developing Countries
- U.S. House Passes Anti-Piracy Bill
- E.U. Eyes Six-Month Marketing Exclusivity For Pediatric Testing
- Federal Judge Strikes Down Anti-Bootlegging Law As Unconstitutional
- India Eyes System For Pre-Grant Patent Opposition In New Patent Regime
- European Union Postpones Decision On Software Patents
- AIPLA Backs Plan To Revamp U.S. Patent System
- Senate Panel OKs Bill To Reform Copyright Arbitration System
- Last Names Can Be Considered For Trademark Registration, European Court Rules
- European Court Of Justice Could Kill Cross-Border Injunctions In Patent Cases
- Drug Companies Target India For R&D Under New Patent Regime
- Senate Appropriators Urged To End USPTO Fee Diversion
- Senate Appropriators Give Nod To USPTO Fee Increase
- U.S. Mulls Reinstating Israel On IPR Blacklist
- Boutiques See Little Impact From Knorr-Bremse Decision
- In Landmark Case, Federal Circuit Redefines Willful Infringement
- U.S. Sends IP Attaché To China Embassy
- Israel Prepares For Clash With U.S., E.U. Over Drug Patent Policy
- American Trade Group Urges U.S. To Take Taiwan Off 301 "Priority Watch List"
- AIPLA, IPO Urge Legislators To Reject USPTO Funding Proposal
- Copyright Arbitration Overhaul Stalled In U.S. Senate
- India Stays Exclusive Marketing Rights For Eli Lilly's Cialis
- Israel Mulls IP Bill That Would Defy U.S., European Demands
- India's Generic Industry Sounds Alarm Over Planned Patent Overhaul
- FDA Holds Off On Biogenerics Decision
- House Panel Clears Bill That Would Criminalize Online Copyright Infringement
- China Defends Decision To Revoke Viagra Patent
- Japan Antitrust Watchdog To Launch Probe On Microsoft Patent Clause In October
- USPTO Panel To Look At Ways To Improve Electronic Filings
- Mylan Laboratories To Refile Hatch-Waxman Suit Vs. FDA